NCT06966583 NAD+ Supplement(NMN)With Radioimmunotherapy in Advanced NSCLC Status NOT_YET_RECRUITING Phase PHASE1
NCT06956248 Innovating Access to Novel Therapies Through Standardized Prospective Integration of Response Evaluations (IMPACT-INSPIRE) Status RECRUITING Phase N/A
NCT06954077 A Study of BL-M09D1 in Patients With Locally Advanced or Metastatic Gastrointestinal Tumors and Other Solid Tumors Status RECRUITING Phase PHASE1
NCT06952010 A Study of XB628 Alone and in Combination With Zanzalintinib in Participants With Recurrent Advanced or Metastatic Solid Tumors Status RECRUITING Phase PHASE1
NCT06949761 A Clinical Study to Evaluate the Safety, Tolerability, and Efficacy of QLC1101 in Combination With Other Therapies in the Treatment of Patients With Advanced Solid Tumors Harboring a KRAS G12D Mutation Status NOT_YET_RECRUITING Phase PHASE1/PHASE2
NCT06939270 CD73/AXL Targeted HypoSti.CAR-T Cells in CD73/AXL Positive Advanced/Metastatic Solid Tumors Status NOT_YET_RECRUITING Phase PHASE1/PHASE2
NCT06932952 A Dose Escalation and Expansion Trial With BYON4228 Alone and in Combination in Patients With Advanced or Metastatic Solid Tumors Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT06911333 AD1208 in Subjects With Any Progressive, Locally Advanced or Metastatic Solid Tumors Status RECRUITING Phase PHASE1/PHASE2
NCT06895681 UCSF Biobank for Hereditary Cancers and Tumor-Associated Mutations Status NOT_YET_RECRUITING Phase N/A
NCT06895031 Study of JYP0015 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS Status RECRUITING Phase PHASE2
NCT06883149 PIN in Combination With Anti-PD1 in Previously Treated Solid Tumor Status RECRUITING Phase PHASE1
NCT06873659 SON-DP in Participants With Relapsed/Refractory Intolerant to Standard of Care Therapies for Advanced/Metastatic Solid Tumors Status RECRUITING Phase PHASE1
NCT06816108 A Study of ONO-7428 in Participants With Unresectable Advanced or Recurrent Solid Tumors Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT06810544 Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss Status RECRUITING Phase PHASE1/PHASE2
NCT06809114 FIH Study to Evaluate Safety, Tolerability, PK, PD & Preliminary Efficacy of AT03-65 With Advanced Solid Tumors Status RECRUITING Phase PHASE1
NCT06801002 Trial to Evaluate the Safety & Tolerability of JBZ-001 in Pts With Advanced Solid and Hematological Malignancies Status RECRUITING Phase PHASE1